Geoffrey C. Dunbar
2009
In 2009, Geoffrey C. Dunbar earned a total compensation of $569.2K as Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer at Catalyst Biosciences, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $83,708 |
|---|---|
| Non-Equity Incentive Plan | $89,821 |
| Option Awards | $88,835 |
| Salary | $292,102 |
| Other | $14,700 |
| Total | $569,166 |
Dunbar received $292.1K in salary, accounting for 51% of the total pay in 2009.
Dunbar also received $83.7K in bonus, $89.8K in non-equity incentive plan, $88.8K in option awards and $14.7K in other compensation.
Rankings
In 2009, Geoffrey C. Dunbar's compensation ranked 6,395th out of 9,885 executives tracked by ExecPay. In other words, Dunbar earned more than 35.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,395 out of 9,885 | 35th |
Division Manufacturing | 2,331 out of 3,690 | 37th |
Major group Chemicals And Allied Products | 509 out of 871 | 42nd |
Industry group Drugs | 344 out of 643 | 47th |
Industry Pharmaceutical Preparations | 242 out of 446 | 46th |
Source: SEC filing on April 21, 2011.
Dunbar's colleagues
We found four more compensation records of executives who worked with Geoffrey C. Dunbar at Catalyst Biosciences in 2009.
2009
J deBethizy
Catalyst Biosciences
Chief Executive Officer
2009
Jeffrey Brennan
Catalyst Biosciences
Senior Vice President, Business and Commercial Development and Chief Business Officer
2009
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2009
Peter Zorn
Catalyst Biosciences